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This research has focused on the development of analytical methods for the 
quantification of benzodiazepines and opiates in forensic samples. Both these classes 
of drugs are regularly encountered in forensic toxicology, especially in cases of fatal 
heroin overdose, and thus quantitative methods for their analysis are particularly 
relevant.
Chapter 1 outlines the nature of the heroin problem in Australia and the different 
drug policies currently employed to help reduce the problems associated with heroin 
use and overdose. The involvement of metabolic factors and CNS depressants, such 
as benzodiazepines, in heroin overdose is discussed. An introduction to post-mortem 
drug analysis, as well as a comprehensive review of previously published methods 
for the analysis of heroin, its metabolites and benzodiazepines in biological samples, 
is presented.
Chapter 2 describes procedures for the synthesis of commonly encountered 
morphine and benzodiazepine metabolites as an alternative to purchasing these 
metabolites commercially. Yields of 48, 25, 74 and 70% were obtained for M3G, 
M6G, 7-aminonitrazepam and 7-aminoclonazepam respectively.
Chapter 3 documents the development of a rapid capillary zone electrophoresis 
(CZE) method for the analysis of nine benzodiazepines using dynamically prepared 
doubly-coated capillaries, consisting of a polycation of 
poly(diallyldimethylammonium chloride) (PDDAC) and a polyanion of dextran 
sulfate (DS). The addition of cyclodextrins to the background electrolyte (BGE) was 
also investigated as a means of improving analysis time. The validated method was 
successfully applied to the analysis of spiked beverages, with run times of less than
6.5 minutes.
xiv
Chapter 4 describes the optimisation of a gradient HPLC separation of nine 
benzodiazepines using artificial neural networks (ANNs) in conjunction with 
experimental design. Various outputs and types of training data were investigated to 
yield the most appropriate ANN, which gave predictive errors of less than 5% for six 
of the nine analytes studied. A novel chromatographic function was also developed 
as a means of assessing the quality of chromatographic separations. The optimised 
method was validated for blood and successfully applied to authentic post-mortem 
samples. The limits of detection of the method ranged from 0.0057 to 0.023 pg/mL, 
and recoveries were in the order of 58 - 92%.
Chapter 5 details the development of a simple and rapid HPLC method for the 
simultaneous determination of morphine, M3G, M6G and codeine. Following SPE, 
the analytes were determined in post-mortem blood samples taken from heroin- 
related deaths. Cases involving the use of benzodiazepines in conjunction with 
heroin were found to have lower ratios of M6G/MOR and M3G/MOR, suggesting 
rapid death following heroin administration. M6G/M3G ratios were calculated to 
investigate the possible contribution of M6G towards heroin overdose with respect to 
its potential analgesic activity. M6G/M3G ratios were higher in cases involving the 
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